Literature DB >> 8581114

The impact of obesity on health status: some implications for health care costs.

J C Seidell1.   

Abstract

Obesity (defined as a body mass index > 30 kg/m2) is common in middle-aged Europeans. The prevalence is notably high in women from Mediterranean and Eastern European countries. In most European countries the prevalence of obesity has been shown to be increasing. When the impact of obesity on health status is assessed this should be done at many levels. Not only should be looked at mortality or diseases and disorders associated with obesity. Physical functioning and quality of life are also of great importance although they may not be bound to any specific diagnosis. Mobility disability has been shown to be more strongly related to obesity than the association between obesity and mortality. Estimation of direct health care costs attributable to obesity vary between 1-5% of the total health care expenditure depending on the definition of obesity and the methods for calculating these costs. This ranks obesity among the major determinants of health care costs.

Entities:  

Mesh:

Year:  1995        PMID: 8581114

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  16 in total

Review 1.  Call for action: preventing and managing the expansive and expensive obesity epidemic.

Authors:  D C Lau
Journal:  CMAJ       Date:  1999-02-23       Impact factor: 8.262

2.  Perceived weight gain as a correlate of physical activity and energy intake among white, black, and Hispanic reproductive-aged women.

Authors:  Yen-Chi L Le; Mahbubur Rahman; Abbey B Berenson
Journal:  J Womens Health (Larchmt)       Date:  2010-09-11       Impact factor: 2.681

Review 3.  Health-economic burden of obesity in Europe.

Authors:  Falk Müller-Riemenschneider; Thomas Reinhold; Anne Berghöfer; Stefan N Willich
Journal:  Eur J Epidemiol       Date:  2008-05-29       Impact factor: 8.082

4.  The impact of obesity on drug prescribing in primary care.

Authors: 
Journal:  Br J Gen Pract       Date:  2005-10       Impact factor: 5.386

Review 5.  Outcomes of pharmacological and surgical treatment for obesity.

Authors:  J Cerulli; M Malone
Journal:  Pharmacoeconomics       Date:  1998-09       Impact factor: 4.981

6.  The cost of obesity in Canada.

Authors:  C L Birmingham; J L Muller; A Palepu; J J Spinelli; A H Anis
Journal:  CMAJ       Date:  1999-02-23       Impact factor: 8.262

7.  Muscle strength and BMI as predictors of major mobility disability in the Lifestyle Interventions and Independence for Elders pilot (LIFE-P).

Authors:  Anthony P Marsh; W Jack Rejeski; Mark A Espeland; Michael E Miller; Timothy S Church; Roger A Fielding; Thomas M Gill; Jack M Guralnik; Anne B Newman; Marco Pahor
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-10-05       Impact factor: 6.053

8.  Multi-centre European experience with intragastric balloon in overweight populations: 13 years of experience.

Authors:  Alfredo Genco; Gontrand López-Nava; Christian Wahlen; Roberta Maselli; Massimiliano Cipriano; Maria Mara Arenas Sanchez; Chantal Jacobs; Michele Lorenzo
Journal:  Obes Surg       Date:  2013-04       Impact factor: 4.129

9.  Effects on energy utilization of a beta3-adrenergic agonist in rats fed on a cafeteria diet.

Authors:  B Berraondo; A Bonafonte; M P Fernandez-Otero; J A Martinez
Journal:  Eat Weight Disord       Date:  1997-09       Impact factor: 4.652

Review 10.  Long-term pharmacotherapy for obesity and overweight.

Authors:  R Padwal; S K Li; D C W Lau
Journal:  Cochrane Database Syst Rev       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.